StonvexLoading…
StonvexStonvexStonvexCore line items from OPY's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.42B | $1.23B | $1.07B | $1.05B |
Operating Income | $211.19M | $105.76M | $46.77M | $45.55M |
Net Income | $148.40M | $71.56M | $30.18M | $32.35M |
EPS (Diluted) | $13.04 | $6.37 | $2.59 | $2.57 |
Total Assets | $3.72B | $3.38B | $2.87B | $2.71B |
Total Liabilities | $2.73B | $2.53B | $2.09B | $1.89B |
Cash & Equivalents | $38.41M | $33.15M | $28.84M | $112.43M |
Free Cash Flow OCF − CapEx | $183.56M | $-113.32M | $-35.87M | $48.18M |
Shares Outstanding | 11.38M | 11.23M | 11.65M | 12.61M |